Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Seeks Comment On Ad Regs: Can Rx Be More Regulated Than OTCs?

Executive Summary

FDA is requesting comment on the legal underpinnings for arguing that promotions of prescription drugs can be more tightly regulated than those for other products

You may also be interested in...



FDA Approps Amendment Targets Chief Counsel Troy; Pfizer Ties Challenged

The House FDA appropriations bill cuts $500,000 from the budget of the chief counsel's office in response to actions taken by Chief Counsel Daniel Troy

DTC Guidance Is High Priority In First Amendment Review, FDA Says

Direct-to-consumer ads are likely to be addressed by FDA early in the upcoming series of First Amendment guidances, Associate Deputy Chief Counsel Seth Ray said during the Food & Drug Law Institute Annual Education Conference in Washington, D.C. April 2

DTC Guidance Is High Priority In First Amendment Review, FDA Says

Direct-to-consumer ads are likely to be addressed by FDA early in the upcoming series of First Amendment guidances, Associate Deputy Chief Counsel Seth Ray said during the Food & Drug Law Institute Annual Education Conference in Washington, D.C. April 2

Related Content

UsernamePublicRestriction

Register

PS039856

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel